These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3545669)

  • 21. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 22. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 23. [The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis].
    Knop P; Kindler U; Merholz T
    Med Welt; 1976 Feb; 27(8):389-90. PubMed ID: 1256308
    [No Abstract]   [Full Text] [Related]  

  • 24. [Allergy to antitubercular agents; with special reference to new drugs].
    Mühlberger F
    Schweiz Med Wochenschr; 1973 Jan; 103(4):126-31. PubMed ID: 4119096
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first-line antituberculosis drugs: Two case reports and a review of the literature.
    Coster A; Aerts O; Herman A; Marot L; Horst N; Kenyon C; Vlieghe E; Hainaut P; Baeck M
    Contact Dermatitis; 2019 Nov; 81(5):325-331. PubMed ID: 31021423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic approach in a case of allergic reaction to antituberculosis drugs -- a case report].
    Costin M; Tesloianu A; Mihăescu T; Butnaru E
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):487-9. PubMed ID: 23077942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eczematous-type multiple drug allergy from isoniazid and ethambutol with positive patch test results.
    Özkaya E
    Cutis; 2013 Sep; 92(3):121-4. PubMed ID: 24153138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy of tuberculosis.
    Pinsker KL; Koerner SK
    Am J Hosp Pharm; 1976 Mar; 33(3):275-83. PubMed ID: 769544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced heart failure in advanced pulmonary tuberculosis.
    Daynes G
    S Afr Med J; 1974 Nov; 48(57):2352-3. PubMed ID: 4432186
    [No Abstract]   [Full Text] [Related]  

  • 30. Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
    Schreiber J; Zissel G; Greinert U; Schlaak M; Müller-Quernheim J
    Eur J Med Res; 1999 Feb; 4(2):67-71. PubMed ID: 10066642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antituberculous drugs.
    Warkany J
    Teratology; 1979 Aug; 20(1):133-7. PubMed ID: 92814
    [No Abstract]   [Full Text] [Related]  

  • 32. [Side effects of tuberculostatics (author's transl)].
    Favez G; Wiser H
    Munch Med Wochenschr; 1973 Sep; 115(39):1685-90. PubMed ID: 4801051
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug-specific CD4
    Ye YM; Hur GY; Kim SH; Ban GY; Jee YK; Naisbitt DJ; Park HS; Kim SH
    Br J Dermatol; 2017 Feb; 176(2):378-386. PubMed ID: 27373553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse drug reactions in TB therapy: risks and recommendations.
    Yoshikawa TT; Nagami PH
    Geriatrics; 1982 Jul; 37(7):61-8. PubMed ID: 7084671
    [No Abstract]   [Full Text] [Related]  

  • 35. Modern management of tuberculosis.
    Promisloff RA; Johnston RF
    Compr Ther; 1979 Oct; 5(10):25-37. PubMed ID: 498742
    [No Abstract]   [Full Text] [Related]  

  • 36. ISONIAZID, PARA-AMINOSALICYLIC ACID, AND STREPTOMYCIN INTOLERANCE IN 1,744 PATIENTS. AN ANALYSIS OF REACTIONS TO SINGLE DRUGS AND DRUG GROUPS PLUS DATA ON MULTIPLE REACTIONS, TYPE AND TIME OF REACTIONS, AND DESENSITIZATION.
    BERTE SJ; DIMASE JD; CHRISTIANSON CS
    Am Rev Respir Dis; 1964 Oct; 90():598-606. PubMed ID: 14221672
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical pharmacokinetics of the antituberculosis drugs.
    Holdiness MR
    Clin Pharmacokinet; 1984; 9(6):511-44. PubMed ID: 6391781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [How to oversee the treatment of tuberculosis?].
    Germouty J; Serizay B; Demonet B; Charles A
    Sem Hop; 1970 Jun; 46(27):1911-4. PubMed ID: 4316120
    [No Abstract]   [Full Text] [Related]  

  • 39. Activation of systemic lupus erythematosus by antitubercular drugs.
    Agarwal MB; Anjaria PD; Mehta BC
    J Postgrad Med; 1980 Oct; 26(4):263-6. PubMed ID: 7230065
    [No Abstract]   [Full Text] [Related]  

  • 40. Adverse effects of antitubercular drugs and significance of measurement of the drug-stimulating lymphocyte transformation rate.
    Umeki S
    Jpn J Med; 1989; 28(3):335-40. PubMed ID: 2739142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.